RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. NGS Super
N

NGS Super portfolio

NGS Super has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Oricell Therapeutics's $70M Series B+ round in January 2026, alongside Qiming Venture Partners, Qatari sovereign wealth fund, Lichen Capital and 4 others. By category, its portfolio leans toward Health and bio (1) and Robotics and hardware (1).

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 1.
Capital in their rounds: $70M.
Latest deal: Oricell Therapeutics · Jan 13, 2026.

What NGS Super invests in

How NGS Super invests

StageDealsCapital in rounds
Series B+ 1 100%$70M

Share is of the 1 round on Recent Funding that name NGS Super. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

NGS Super portfolio companies

CompanyRound with NGS SuperTotal raisedLatest raise
OOricell Therapeutics
Health and bio
Series B+ · $70M$235MApr 10, 2026
round
UUniversal Quantum
Robotics and hardware
backer$100MOct 8, 2026
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists NGS Super, which is a subset of its real portfolio. API: /api/v1/investors/ngs-super (get a free API key). More: the most active VC firms and new venture capital funds.